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(54) Fluorescent dyes and dye precursors
(57) A xanthene compound is used for discriminating living from non-living unicellular and multicellular organisms.
The xanthene compound is represented by the following formula (I)
wherein
each X is, independently from each other, one of H, F, Cl, Br, I, CN;
Z is one of O, Si, Ge or Sn;
R1 is hydrogen, -(C=O)-R4 or -CH2-O-(C=O)-R4, wherein R4 is substituted or unsubstituted alkyl having 1 to 18 carbon
atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having
at least 7 carbon atoms, or wherein R1 is a residue derived from an amino acid, peptide, nucleotide or oligonucleotide,
monosaccaride or polysaccharide;
A is -NH2, -OR1 or -NR5(C=O)-R4 wherein R4 independently has the meaning as defined above and R5 is H,
substituted or unsubstituted alkyl having 1 to 18 carbon atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon
atoms, or substituted or unsubstituted aralkyl having at least 7 carbon atoms;
R2 and R3 are, independently from each other, H or -(C=O)-NR6R7, wherein at least one of R2 and R3 is not H, and
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wherein R6 and R7 are selected from H, substituted or unsubstituted alkyl having 1 to 18 carbon atoms, substituted or
unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having at least 7 carbon atoms.
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Description
FIELD OF THE INVENTION
[0001] The invention relates to fluorescent dyes and dye precursors, and in particular to cell permeating xanthene
compounds, as well as the use of these compounds for discriminating living from non-living unicellular and multi-cellular
organisms.
BACKGROUND OF THE INVENTION
[0002] Fluorescent dyes generally bear charged chemical groups or functions that hinder their penetration into cells.
Chemical groups such as ester groups can be used to mask the charge and/or mask the fluorescence properties in a
reversible manner. Such a chemical group is called "protective group" or "blocking group" in the following, and their
grafting onto dyes leads to blocked dye precursors or pro-dyes.
[0003] In the process of discriminating living cells from non living cells, the protective groups are selected for their
capacity to both permit dye penetration into cells by passive diffusion, and at the same time mask the fluorescent
properties of the dye. The living cell, in contrast to the non-living (dead) cell, contains enzymes that can unblock the dye
precursor by cleaving the protective group. This cleavage has two consequences: the dyes become sequestered in the
cell resulting in an accumulation of the dyes, and their fluorescence properties are relieved so that the dyes become
detectable.
[0004] US-A-4318846 describes symmetrically substituted diether fluoresceins having at least an anionic group and
a linking functionality. At least some of the substituents on the aromatic rings may be halogen including fluorine. The
compounds are used in fluorescent immunoassays.
[0005] WO 1997/039064 A1 discloses the preparation of xanthene derivatives including fluoresceins and rhodols that
are directly substituted on one or more aromatic carbon atoms by fluorine. These fluorinated fluorescent dyes are useful
as detectable tracers and for preparing conjugates of organic and inorganic substances.
[0006] The article of Yuichiro KOIDE et al., "Evolution of group 14 rhodamines as platforms for near-infrared fluores-
cence probes utilizing photoinduced electron transfer", ACS Chem. Biol.6, 600-608 (2011), describes the preparation
of pyronine and rhodamine analogs in which the oxygen atom at position 10 is replaced by Si, Ge or Sn to provide a
large bathochromic shift to the original rhodamines. These molecules retain the advantages of the original rhodamines,
including high quantum efficiencies in aqueous media, tolerance to photobleaching and high water solubility. They are
thus suitable for intravital labeling of living cells with high signal-to-noise ratio.
[0007] Carboxyfluorescein diacetate (CDFA), as a dye precursor for intravital labeling of living cells using host cell
esterases to unblock hydroxyl groups, is disclosed in the following publications:
a) T.H. Chrzanowski et al., "Applicability of the fluorescein diacetate method of detecting active bacteria in fresh
water", Microb Ecol (1984) 10:179-185; and
b) Thomas A. Robertson, et al., "Fluorescein Derivatives in Intravital Fluorescence Imaging", Cells 2013, 2(3),
591-606.
[0008] The article of L. D. Lavis et al., "Synthesis and utility of fluorogenic acetoxymethyl ethers", Chem Sci., 2011,
2, 521-530 discloses that acetoxy-methyl esters of fluoresceine (4a) and Oregon green (4b) are suitable profluorophores
for intravital labeling of cells:
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[0009] In an article of D. Hoefel et al., "A comparative study of carboxyfluorescein diacetate and carboxyfluorescein
diacetate succinimidyl ester as indicators of bacterial activity", Journal of Microbiological Methods 52 (2003) 379-388,
it was found that carboxyfluorescein diacetate (CFDA) was successful in detecting active bacteria, by qualitative and
quantitative analysis of exponential phase cultures, mixtures of active and inactive cells and bacteria from environmental
waters whereas carboxyfluorescein diacetate succinimidyl ester (CFDA/SE) was not. CFDA/SE labelled inactive cells
with intensities equal to that of the active population and could not even discriminate between bacteria in exponential
phase growth and a fixed cell preparation.
[0010] The article of P. Breeuwer et al., "Characterization of uptake and hydrolysis of fluorescein diacetate and car-
boxyfluorescein diacetate by intracellular esterases in Saccharomyces cerevisiae, which result in accumulation of fluo-
rescent product", Appl Environ Microbiol. Apr 1995; 61(4): 1614-1619, shows that not only bacteria, but also yeast cells
can be labeled with fluorescein and carboxyfluoresceine derivatives.
[0011] The article by Vince Boyd et al., "Limitations in the Use of Fluorescein Diacetate/Propidium Iodide (FDA/PI)
and Cell Permeable Nucleic Acid Stains for Viability Measurements of Isolated Islets of Langerhans", Curr Trends
Biotechnol Pharm . 2008 March ; 2(2): 66-84, shows that also mammalian cells can be stained using fluorescein diacetate.
[0012] FR 2 955 121 A claims a culture medium for microorganisms, comprising a nutrient medium in which are
homogeneously dissolved at least one fluorogenic substrate and a compound for masking residual fluorescence asso-
ciated with non-specific activation of said fluorogenic substrate. CFDA is used as the fluorogenic substrate in combination
with a contrast agent to reveal living bacteria.
[0013] WO2006003696 (A1) entitled "Method of Determining Viable Cell Count and Apparatus Therefor" focuses on
the use of CFDA for the enumeration of viable cells in a sample, including microbes. A specimen is stained with the use
of carboxyfluorescein diacetate and trypan blue, and irradiated with carboxyfluorescein diacetate excitation light. The
fluorescence emitted by the specimen is collected, captured as an image, and converted to an electrical signal to thereby
determine a viable cell count.
[0014] JP2004187534 (A) entitled "Method for Evaluating Physiological Activity of Microorganism or Cell and Kit
Therefor" relates to a method of analyzing the physiological activity of cells based on a fixation step, a revelation step
using CFDA and a washing step. In particular, the method comprises a process for collecting the microorganism or the
cell by adhesion or transfer with an adhesive sheet, a process for dyeing the microorganism or the cell with a solution
containing carboxyfluorescein diacetate, and a process for cleaning the dyed microorganism or cell with a cleaning liquid.
[0015] US2008220439 A1 relates to a microorganism detecting kit including a self-adhesive layer containing the
following compounds incorporated therein: 4’,6-diamidino-2-phenylindole dihydrochloride for staining living and dead
cells, propidium iodide 3 for staining dead cells, 6-carboxyfluorescein diacetate for staining living cells and 4-methylum-
belliferyl-beta-D-galactoside reacting with a substance derived from particular microorganisms, a support and a grip
portion. Microorganisms deposited to a specimen are deposited to the self-adhesive layer, and then the compounds
react with the microorganisms and are bonded individually to the microorganisms to color them. The microorganism
detecting kit is used to confirm of the presence of living and dead cells, dead cells and living cells by counting the colored
cells in an adding manner.
[0016] There is still a need for improved fluorescent dye precursors ("pro-fluorophores") which can be used for dis-
criminating living from non-living organisms in biological or industrial samples.
SUMMARY OF THE INVENTION
[0017] In one aspect, the invention is a xanthene derivative including blocked fluorescein and rhodol derivatives having
an improved permeability through the cell membrane of bacteria and other living organisms. The xanthene derivatives
of the present invention are useful pro-fluorophores for cell viability tests such as in drinking water or other samples.
[0018] In a further aspect, the invention is directed to the fluorophores obtained by unblocking the xanthenes pro-
fluorophores of the first aspect of the invention.
[0019] The inventors found that carboxyfluorescein diacetate (CFDA) still has a free carboxylic acid group in 5- or 6-
position at the bottom ring:
EP 3 050 886 A1
5
5
10
15
20
25
30
35
40
45
50
55
[0020] At physiological pH, this carboxylic acid group is mostly ionized (-COO-) which makes it less prone to diffusion
through biological membranes that are made up of hydrophobic and apolar lipid chains. Accordingly, the free acid group
on CFDA is likely to significantly reduce the fraction of reagent entering the cells.
[0021] The inventors therefore contemplate that blocking the free carboxylic acid group in addition to the hydroxyl
groups would improve the efficacy of the xanthene dye precursors.
[0022] Accordingly, the present invention provides a compound represented by the following formula (I)
wherein
each X is, independently from each other, one of H, F, Cl, Br, I, CN;
Z is one of O, Si, Ge and Sn;
R1 is hydrogen, -(C=O)-R4 or -CH2-O-(C=O)-R4, wherein R4 is substituted or unsubstituted alkyl having 1 to 18 carbon
atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having
at least 7 carbon atoms, or wherein R1 is a residue derived from an amino acid, peptide, nucleotide or oligonucleotide,
monosaccaride or polysaccharide;
A is -NH2, -OR1 or -NR5(C=O)-R4 wherein R4 independently has the meaning as defined above and R5 is H, substituted
or unsubstituted alkyl having 1 to 18 carbon atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms,
or substituted or unsubstituted aralkyl having at least 7 carbon atoms;
R2 and R3 are, independently from each other, hydrogen or -(C=O)-NR6R7, wherein at least one of R2 and R3 is not
hydrogen, and wherein R6 and R7 are selected from hydrogen, substituted or unsubstituted alkyl having 1 to 18 carbon
atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having
at least 7 carbon atoms.
[0023] Optional substituents are preferably selected from the group consisting of F, Cl, Br, I, CN, hydroxyl, ether,
amino, carboxylic acid, carboxylic acid esters of an aliphatic alcohol or phenol.
[0024] In a specific embodiment, the compound is represented by the following formula (II):
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wherein X, R2 and R3 each have the meaning as defined above, each R1 are the same or different from each other and
are hydrogen, -(C=O)-R4 or -CH2-O-(C=O)-R4, wherein R4 independently is substituted or unsubstituted alkyl having 1
to 18 carbon atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted
aralkyl having at least 7 carbon atoms.
[0025] More preferably, X is H or F, and R4 independently is alkyl having 1 to 8 carbon atoms, more preferably methyl
or ethyl.
[0026] R2 or R3 preferably is -(C=O)-NH-R7 wherein R7 is alkyl having 1 to 8 carbon atoms, more preferably alkyl
having 1 to 4 carbon atoms.
[0027] In a more preferred embodiment, X in formula (II) is H, both R1 are either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4
is methyl, and one of R2 and R3 is -(C=O)-NH-R7, wherein R7 is selected from methyl, ethy, propyl, isopropy, butyl,
isobutyl, more preferably propyl.
[0028] In a further preferred embodiment, X in formula (II) is F both R1 are either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4
is methyl, and one of R2 and R3 is -(C=O)-NH-R7 wherein R7 is selected from methyl, ethy, propyl, isopropy, butyl,
isobutyl, more preferably propyl.
[0029] In another specific embodiment, the compound is represented by the following formula (III):
wherein X, R2 and R3 have the meaning as defined above, R1 is -(C=O)-R4 or -CH2-O-(C=O)-R4, and A is -NH2, or
-NR5(C=O)-R4, wherein each R4 independently is substituted or unsubstituted alkyl having 1 to 18 carbon atoms, sub-
stituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having at least 7
carbon atoms, and wherein R5 is H, substituted or unsubstituted alkyl having 1 to 18 carbon atoms, substituted or
unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having at least 7 carbon atoms.
[0030] More preferably, X is H or F, A is -NR5(C=O)-R4, R4 independently is alkyl having 1 to 4 carbon atoms, more
preferably methyl or ethyl, and R5 is H or alkyl having 1 to 4 carbon atoms, more preferably hydrogen, methyl or ethyl.
[0031] R2 or R3 preferably is -(C=O)-NH-R7 wherein R7 is alkyl having 1 to 8 carbon atoms, more preferably alkyl
having 1 to 4 carbon atoms.
[0032] In a more preferred embodiment, X in formula (III) is H, R1 is either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4 is
methyl, R5 is H, and one of R2 and R3 is -(C=O)-NH-R8 wherein R8 is selected from methyl, ethy, propyl, isopropy, butyl,
isobutyl, more preferably propyl.
[0033] In a further preferred embodiment, X in formula (II) is F, R1 is either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4 is
methyl, R5 is H, and one of R2 and R3 is -(C=O)-NH-R8 wherein R8 is selected from methyl, ethy, propyl, isopropy, butyl,
isobutyl, more preferably propyl.
[0034] In a further aspect, the compounds according to the invention are used for staining a biological sample.
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[0035] Preferably, the biological sample comprises a living cell, and more preferably the living cell is a unicellular or
multicellular organism.
[0036] In a preferred embodiment, the sample is incubated with the compound according to the invention for a time
sufficient for the compound to yield a detectable fluorescence emission, and more preferably, the fluorescence emission
is evaluated to discriminate living from non-living cells. More specifically, the above compounds are used in a method
to discriminate living cells from non-living cells by incubating a sample containing the cells with a compound according
the invention, and determining the fluorescence emitted from the compounds after cleavage of the protective groups
-(C=O)-R4 by enzymes present in the living cells.
[0037] In a preferred method, the compounds are used to determine the presence of bacteria such as E. coli in food
samples and/or drinking water.
[0038] The above methods preferably comprise the step of subjecting the incubated biological sample to a cytometric
assay or an immunological assay.
[0039] In a further aspect, the invention provides a culture medium for microorganisms, comprising a compound
according to the invention dissolved in the culture medium, and optionally a nutrient medium. Suitable nutrient media
for microorganisms are known to the person skilled in the art, as shown for example in FR 2 955 121 A.
[0040] The compounds according to the invention may also be used in combination with other fluorescent dyes,
contrast media or other material such as propidium iodide and/or 4-methylumbelliferyl-beta-D-galactoside, as may be
required by any specific assay.
[0041] In a preferred embodiment, the stained biological sample is treated with a contrast agent. More preferably, the
contrast agent is selected from the group consisting of Brilliant Blue R, Trypan Blue and Bromophenol Blue.
BRIEF DESCRIPTION OF THE DRAWINGS
[0042] The invention is now described in more detail with reference to specific embodiments and the drawings which
are understood as non-limiting examples. In the drawings:
- Figure 1 is a graph showing the short-term stability of fluorescein derivatives according to the present invention;
- Figure 2 is a graph showing the long-term stability of fluorescein derivatives according to the present invention;
- Figure 3 shows a series of photomicrographs illustrating the labeling of different bacteria using pro-fluorophores
according to the present invention, wherein (a) shows viable or dead waterborne Enterobacter cloacae, (b) shows
Chryseobacterium indologenes, (c) shows Pseudomonas aeruginosa, and (d) shows Bacillus subtilis;
- Figure 4 shows a series of photomicrographs illustrating the labeling of viable E. coli using xanthenes derivatives
of the present invention;
- Figure 5 shows a graph illustrating the relative rate of fluorescence intensity in viable or dead E. coli using various
pro-fluorophores of the present invention; and
- Figure 6 shows a graph illustrating the effect of incubation time on the fluorescence intensity of stained viable E. coli.
DESCRIPTION OF PREFERRED EMBODIMENTS
Synthesis of fluorophores and pro-fluorophores derived from fluorescein and Oregon Green™
[0043] Techniques currently used to evaluate bacterial viability are based on the use of fluorogenic substrates. One
of these substrates well described and adapted for this application is 5-carboxyfluorescein diacetate (5-CFDA). However,
5-CFDA has a carboxylic acid functional group bearing a negative charge according to the pH (∼7) of the solution used
to stain bacteria, which reduces the uptake of the pro-fluorophore in the bacteria.
[0044] According to the invention, new fluorogenic esterase substrates are used to improve the detection of viable E.
coli (gram-negative bacteria) by improving intracellular delivery using different uncharged functional groups. Fluorine
and acetoxymethyl (AM) substitution are also proposed in order to modify the hydrolysis speed of the pro-fluorophore
according to the invention. After pro-fluorophore hydrolysis, the fluorophores are retained more efficiently inside the
bacterial cell.
[0045] Reagents were obtained from commercial sources and used without further purification. Particular fluorophore
based reagents are:
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5-carboxyfluorescein succinimidyl ester (from Life Technologies);
Oregon Green® 488 carboxylic acid (from Life Technologies);
fluorescein isothiocyanate isomer I (from Sigma Aldrich); and
5,6-carboxyfluorescein (from Kodak).
[0046] Semi preparative reverse-phase high performance liquid chromatography (RP-HPLC) separations were per-
formed on a SunFire™ C18 OBD™ Prep column (5 mm, 19 mm x 150 mm) from Waters™ using a linear gradient of
solvent B in solvent A of 5% to 100% for 25 min, wherein solvent A was water with 0.1% trifluoroacetic acid (TFA) and
solvent B was acetonitrile with 0.1% TFA. The flow rate was 20 ml/min; detection was at 220 nm and 254 nm.
[0047] Analytical reverse-phase high performance liquid chromatography (RP-HPLC) separations were performed on
a Ascentis® Express C18 column (2.7 mm, 4.6 mm x 75 mm) from Supelco™ using a linear gradient of 5% to 100% of
solvent B in solvent A for 7.5 min. The flow rate was 1.6 ml/min, and detection was at 220 nm and 254 nm.
[0048] Purified final compounds eluted as single and symmetrical peaks at retention times (tR) given below. Their
identity was determined by high resolution mass spectroscopy (HRMS). Intermediates were analyzed by liquid chroma-
tography mass spectroscopy (LCMS) using a multi-mode MM-ES+APCI source.
Example 1 (Not Inventive)
1-(3’,6’-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthen]-5-yl)-3-propylthiourea (5-PFT)
[0049]
[0050] N,N-diisopropylethylamine (DIEA) (25 ml, 154 mmol) and propylamine (4.2 ml, 51 mmol) were added to a solution
of fluorescein-5-isothiocyanate (10 mg, 25 mmol) in anhydrous DMSO (5 ml) The reaction mixture was stirred overnight
in the dark, at room temperature and freeze-dried to yield the compound as an orange oil. The crude product was used
in the next step without further purification. tR = 4.10 min, RP-HPLC purity: >90%, MS (ESI) m/z: 449.0 (M+H)+
Example 2
2’,7’-difluoro-3’,6’-dihydroxy-3-oxo-N-propyl-3H-spiro[isobenzofuran-1,9’-xanthene]-5-carboxamide (5-POG)
[0051]
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[0052] N,N-diisopropylethylamine (DIEA) (7.8 ml, 47 mmol) and propylamine (2 ml, 23.5 mmol) were added to a solution
of Oregon Green® 488 carboxylic acid succinimidyl ester, isomer 5 (4 mg, 7.8 mmol) in anhydrous DMSO (2.5 ml). The
reaction mixture was stirred in the dark overnight at room temperature, and freeze-dried to yield the compound as an
orange oil. The crude product was used in the next step without further purification. 1H NMR (DMSO, 500 MHz): δ 10.78
(bs, 1 H), 8.82 (t, J = 5.6 Hz, 1 H), 8.47 (s, 1 H), 8.26 (dd, J = 8.1 Hz, J = 1.6 HZ, 1H), 7.39 (d, J = 8.2 Hz, 1H), 6.89 (d,
7.6 Hz, 2H), 6.58 (d, J = 11.3 Hz, 2H), 1.60-1.55 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H); tR = 4.03 min, RP-HPLC purity: >90%,
MS (ESI) m/z: 454.0 (M+H)+
Example 3
3’,6’-dihydroxy-3-oxo-N-propyl-3H-spiro[isobenzofuran-1,9’-xanthene]-5-carboxamide (5-PFA)
[0053]
[0054] DIEA (10 ml, 64 mmol) and propylamine (2.6 ml, 31.7 mmol) were added to a solution of 5-carboxyfluorescein
succinimidyl ester (5 mg, 10.5 mmol) in anhydrous DMSO (2.5 ml). The reaction mixture was stirred in the dark overnight
at room temperature, and freeze-dried to yield the compound as an orange oil. The crude product was used in the next
step without further purification. 1H NMR (DMSO, 500 MHz): δ 10.16 (bs, 1H), 8.81 (t, J = 5.4 Hz, 1H), 8.46 (d, J = 0.5
Hz, 1 H), 8.24 (dd, J = 8.1 Hz, J = 1.6 Hz, 1 H), 7.37 (d, J = 8 Hz, 1 H), 6.59-6.53 (m, 4H), 3.29-3.25 (m, 2H), 1.59-1.55
(m, 2H), 0.92 (t, J = 7.4 Hs, 3H); 13C NMR (DMSO, 125 Mhz): δ 168.2, 164.5, 159.6, 154.5, 151.8, 136.4, 134.7, 127.2,
126.4, 124.2, 123.2, 112.7, 109.1, 102.3, 41.2, 22.3, 11.5. tR = 3.79 min, RP-HPLC purity: >90%, %, MS (ESI) m/z:
418.0 (M+H)+.
Example 4 (Not Inventive)
Propyl-3’,6’-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthene]-5-carboxylate & propyl-3’,6’-dihydroxy-3-
oxo-3H-spiro[isobenzofuran-1,9’-xanthene]-6-carboxylate (5,6-PFE)
[0055]
[0056] DIEA (33 ml, 0.2 mmol) and 1-bromopropane (12 ml, 0.13 mmol) were added to a solution of 5,6-carboxyfluo-
rescein (25 mg, 66 mmol) in anhydrous DMSO (1 ml). The reaction mixture was stirred at 35 °C in the dark for 48 h and
purified by reverse-phase HPLC to yield isomer 5 (10.7 mg, 38%) and isomer 6 (9.6 mg, 35%) as orange solids. For
isomer 5: tR = 4.96 min, RP-HPLC purity: >95%, HR-MS for C24H18O7: calculated 418.1053, found 418.1033.
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General procedure for acetylation
[0057] Pyridine (0.52 mmol, 60 equiv.) and acetic anhydride (0.63 mmol, 50 equiv.) were added to a solution of a 3’,6’-
dihydroxy-xanthene compound (10 mmol, 1 equiv.) in a mixture of anhydrous CH2Cl2/DMF (2.4 ml, 5/1). The reaction
mixture was stirred in the dark at room temperature for 4 h. All compounds were isolated by reverse-phase HPLC to
give the desired product (18-83% yield).
Example 5 (Not Inventive)
3-oxo-5-(3-propylthioureido)-3H-spiro[isobenzofuran-1,0’-xanthene]-3’,6’-diyl diacetate (5-PFDAT)
[0058]
[0059] Acetylation of the compound of Example 1 resulted in a yellow solid; yield 2.4 mg (18% over 2 steps); tR = 5.37
min, RP-HPLC purity: ≥87%, HR-MS for C28H24N2O7S: calculated 532.1304, found 532.1310
Example 6
2’,7’-difluoro-3-oxo-5-(propylcarbamoyl)-3H-spiro[isobenzofuran-1,9’-xanthene]-3’,6’-diyl diacetate (5-POGDA)
[0060]
[0061] Acetylation of the compound of Example 2 resulted in a yellow solid; yield 4.5 mg (76% over 2 steps); tR = 5.51
min, RP-HPLC purity: ≥95%, HR-MS for C28H21F2NO8: calculated 537.1235, found 537.1236.
Example 7
3-oxo-5-(propylcarbamoyl)-3H-spiro[isobenzofuran-1,9’-xanthene]-3’,6’-diyl diacetate (5-PFDA)
[0062]
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[0063] Acetylation of the compound of Example 3 resulted in a yellow solid; yield 3.2 mg (60% over 2 steps); tR = 5.21
min, RP-HPLC purity: ≥89%, HR-MS for C28H23N1O8: calculated 501.1424, found 501.1424.
Example 8 (Not Inventive)
3-oxo-5-(propoxycarbonyl)-3H-spiro[isobenzofuran-1,9’-xanthene]-3’,6’-diyl diacetate (5-PFDAE)
[0064]
[0065] Acetylation of the compound of Example 4 resulted in a yellow solid;Yellow solid; yield 4.2 mg (70%); tR = 6.28
min, RP-HPLC purity: ≥95%, HR-MS for C28H2209: calculated 502.1264, found 502.1261.
Example 9 (Not Inventive)
3’,6’-diacetoxy-2’,7’-difluoro-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthene]-5-carboxylic acid (5-COGDA)
[0066]
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[0067] Acetylation of Oregon Green™ 488 carboxylic acid resulted in a yellow solid; yield 10 mg (83%); tR = 5.10 min,
RP-HPLC purity: ≥98%, HR-MS for C25H14F2O9: calculated 496.0606, found 496.0623.
Example 10
2’,7’-difluoro-3-oxo-5-(propylcarbamoyl)-3H-spiroisobenzofuran-1,9’-xanthene-3’,6’-diyl diacetoxymethyl ether 
(5-POGAM)
[0068]
[0069] The compound of Example 2, (8.8 mg, 0.019 mmol), powdered 4-A molecular sieves (10 mg), and Ag2O (11
mg, 0.048 mmol) were suspended in anhydrous CH3CN (0.5 ml) under argon. Bromomethyl acetate (7.6 ml, 0.077 mmol)
was added, and the reaction mixture was stirred for 48h. The reaction mixture was then filtered through a pad of celite.
The solution was concentrated under reduced pressure. A purification by reverse-phase HPLC, followed by column
chromatography (silica gel, 5 to 20% EtOAc in CH2Cl2) gives the desired product as a white solid (4.8 mg, 41%). tR =
5.33 min, RP-HPLC purity: >95%, HR-MS for C31H21F2NO13: calculated 653.0981, found 653.0979.
Spectroscopic properties
[0070] Absorption spectra were recorded in a 1-cm path length cuvette (Hellma, 104.002B-QS) on a SPECORD®-
205 spectrometer from Analytik Jena.
[0071] The Extinction coefficients of the flourophores fluorescein, 5-carboxyfluorescein (5-CF), 5-carboxy Oregon
Green™ (5-COG), 5-amido N-propyl Oregon Green (5-POG; Example 2) and 5-amido N-propyl fluorescein (5-PFA;
Example 3) were measured in 0.1 M NaOH solution at pH 12.7.
[0072] The extinction coefficients of the pro-fluorophores 5-thiourea N-propyl fluorescein diacetate (5-PFDAT; Example
5), 5-propyl carboxylate fluorescein diacetate (5-PFDAE; Example 8), 5-amido N-propyl fluorescein diacetate (5-PFDA;
Example 7), 5-carboxy Oregon Green diacetate (5-COGDA; Example 9), 5-amido N-propyl Oregon Green diacetate (5-
POGDA; Example 6) and 5-amido N-propyl Oregon Green acetoxymethylester (5-POGAM; Example 10) were measured
in PBS buffer containing 0.6 % glutaraldehyde at pH 7.
[0073] Fluorometric measurements were made using fluorescence grade quartz cuvette and FluoroLog®-3 spec-
trofluorometer from Horiba Jobin Yvon equipped with sample stirring. The quantum yields (QY) of 5-CF, 5-COG, 5-POG
and 5-PFA were measured with samples at 1 mM (absorbance 488 nm ≤ 0.2) in 0.1 M NaOH at pH 12.7. Every sample
and the standard (fluorescein) was prepared freshly before use. In this study, fluorescein in 0.1 M NaOH at pH 12.7 was
the reference system with a known quantum yield (Φ = 0.925).
[0074] Quantum yield measurements were done using standard absorption and emission spectrometers. Emission
spectra range was between the wavelengths 498 - 600 nm and excitation wavelength was 488 nm for the samples and
fluorescein. The refractive indices of the samples and fluorescein solutions were the same since they were prepared in
the same buffer. Under these conditions, quantum yields were calculated by using the equation: 
[0075] wherein Φi and Φs are the photoluminescence QY of the sample and standard (fluorescein), respectively; Fi
and Fs are the integrated intensities (areas) of sample and fluorescein spectra, respectively; and fi and fs are the absorption
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factor of the sample and fluorescein, respectively, with fi or s = 1-10-Ai or s, wherein A = absorbance.
[0076] The same experiment was repeated three times (n = 3).
[0077] The spectroscopic properties obtained from these measurements are listed in the following Table 1. The results
show that the fluorophores of the present invention present fluorescence characteristics similar to fluorescein, carbox-
yfluorescein, and carboxy Oregon Green. 5-POG is the fluorophore obtained after unblocking of 5-POGDA or 5-POGAM
by ester hydrolysis. The quantum yield of 5-POG ist not significantly altered as compared to fluorescein, carboxyfluo-
rescein and carboxy Oregon Green.
Chemical stability tests
[0078] Pro-fluorophores must be stable in aqueous solution to be useful in biological assays. Hydrolysable substrates
can have insufficient stability because spontaneous hydrolysis can compete with enzymatic activity and therefore raise
the background fluorescence level.
[0079] The short-term chemical stability of the pro-fluorophores of the present invention in an aqueous buffer was
evaluated by fluorometric measurement analysis after several minutes of storage at 37°C.
[0080] Each pro-fluorophore (5-CFDA, 5-PFDAE, 5-PFDAT, 5-PFDA, 5-COGDA, 5-POGDA, 5-POGAM) was dissolved
in dimethylsulfoxide (DMSO) in order to prepare a 10 mM stock solution. Short-term stability studies (0-60 min) were
performed in the absence of light at 37°C. The pro-fluorophore stock solutions were diluted into a PBS solution containing
0.6 % of glutaraldehyde (pH ∼7). The pro-fuorophore final concentration was 15 mM. Samples were stored in a fluores-
cence grade quartz cuvette having a volume of 1 ml. Fluorescence emission spectra between 500 and 540 nm were
recorded every 10 minutes. The excitation wavelength used was 488 nm. Fluorometric measurement were made with
a FluoroLog®-3. (Horiba Jobin Yvon) spectrofluorometer equipped with sample stirring. The same experiment was
repeated three times (n = 3).
[0081] As shown in Figure 1, the straight line represents the fluorescence intensity of the formed product during time.
Thus, the slope of the straight line corresponds to the speed of spontaneous fluorescence generation. The relative speed
of spontaneous fluorescence generation from 5-POGAM is almost four times slower than that of 5-CFDA. 5-PFDAE
showed also remarkable stability in PBS solution containing 0.6 % glutaraldehyde. In contrast, 5-COGDA and 5-POGDA
have rapid spontaneous hydrolysis in this solution, eight times higher and almost six times higher, respectively, than 5-
CFDA.
[0082] The above tests indicate that pro-fluorophores with fluorine substitution, like 5-COGDA and 5-POGDA, are less
stable as compared to 5-CFDA and 5-PFDA having no fluorine substitution. The data confirm that fluorine substituted
pro-fluorophores are more prone to hydrolysis in an aqueous buffer solution.
[0083] To examine whether the pro-fluorophores 5-POGDA and 5-POGAM could be stored for at least two months in
solution at room temperature (23 6 2 °C) and in the absence of light, they were dissolved in anhydrous DMSO solvent
and analysed by liquid chromatography-mass spectrometry. The analysis was performed using an UHPLC-MS/MS
system (LC-MS 8030, Shimadzu). 5-POGDA or AM (120 mM) were stored in anhydrous DMSO. A solution of 5-CFDA
Table 1
Compound λAbs max (nm) E (M-1.cm-1) λex (nm) λem (nm) Φ
Fluorescein 491 87458 6 8271 490 6 0.3 512 6 0.5 0.925
5-CF 493 76474 6 4009 491 6 0.7 517 6 0.6 0.963 6 0.004
5-COG 493 83136 6 4452 491 6 1.2 517 6 0.4 0,912 6 0.011
5-POG 495 74835 6 4762 493 6 0.6 518 6 1.1 0,902 6 0.013
5-PFA 495 73490 6 8454 493 6 0.3 518 6 0.4 0,835 6 0.002
5-PFDAT ND ND ND ND ND
5-PFDAE 295 7903 6 761 ND ND ND
5-PFDA 291 9284 6 758 ND ND ND
5-COGDA 300 6979 6 282 ND ND ND
5-POGDA 303 9784 6 351 ND ND ND
5-POGAM 302 11165 6 334 ND ND ND
ND: not determined
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(20 mM) in acetonitrile stored at -80°C was used as internal reference for HPLC-MS/MS analysis. The solution injected
was composed of 5-POGDA or AM (1.2 mM), and 5-CFDA (0,2 mM) in H2O/acetonitrile, ratio 1/1 (V/V).
[0084] Data acquisition and analysis were performed using LabSolutions version 5 software. A 1.7 mm Kinetex™
column (50 X 2.1 mm) was used for HPLC. The mobile phase flow rate was fixed at 0.5 ml/min and the following program
was applied for the elution: 0-1.2 min, 5-95% B; 1.2-1.4 min, 95% B; 1.4-1.42 min, 95-0% B and 1.42-2.8 min, 5% B.
Solvent A consisted of 0.05% formic acid in water and solvent B was HPLC grade acetonitrile. 1 ml was injected.
[0085] The mass spectrometer was interfaced with the UHPLC system using an electrospray ion source. The instru-
mental parameters were as follows: nebulizer gas, 2 I /min; DL temperature, 250°C; block heater temperature, 400°C;
interface voltage, 4.5 kV; collision energy, between -12 and -22V. The collision gas used was argon at 230 kPa. The
MRM transitions were m/z 598.2 → 454.1, 538.1 → 454.1 and 454.1 → 368.0, respectively for 5-POGAM, 5-POGDA
and 5-POG. The dwell time was set to 30 msec and the pause time to 3 msec. The percentage of remaining test compound
relative to t0 was measured using the peak area on the chromatogram.
[0086] The result of the long-term stability tests are shown in Fig. 2. The percentage of 5-POGDA and 5-POGAM
remaining in the solution is calculated to be around 18 % and 65 % respectively after 77 days. The side product of 5-
POGAM in DMSO after 77 days found by mass scan corresponded to mono-hydrolysed 5-POGAM. Conversely, in the
solution of 5-POGDA, the majority amount was the fluorophore 5-POG shown by mass scan analysis, and no mono-
hydrolysed product was detected. The present results suggest that for a long-term storage (< 2 months) of the pro-
fluorophore in solution at room temperature in darkness, 5-POGAM can be dissolved in anhydrous DMSO in a disposable
system.
[0087] Together, the stability tests show that 5-POGAM (Example 10) possess greater chemical stability in aqueous
solution.
Bacteria Staining Tests
[0088] Esterases are present in all living organisms, and these enzymes can be used to provide information on bacterial
viability. The pro-fluorophores of the present invention, 5-POGDA, 5-POGAM, and a prior art compound, 5-CFDA were
compared with respect to their ability to stain several bacterial species.
[0089] Escherichia coli (E. coli) (ATCC 8739) and Bacillus subtilis (B. subtilis) (ATCC 6633) strains were routinely
grown in Luria Bertani (LB) broth or on LB agar plates for 18h at 37 °C. Waterborne environmental bacteria such as
Enterobacter cloacae (E. cloacae), Chryseobacterium indologenes (C. indologenes), Pseudomonas aeruginosa (P.
aeruginosa), and E. coli (EC18) were purchased from Eurofins™. Environmental bacteria were grown in LB broth or on
casein-peptone soymeal-peptone agar plates for 18h at 37 °C.
[0090] For the staining tests, E. coli (ATCC 8739 or EC18), E. cloacae, C. indologenes, P. aeruginosa and B. subtilis
were cultivated in Luria-Bertani (LB) broth until exponential phase at 37°C with shaking at 300 rpm revolutions per
minutes (rpm). Bacteria were harvested and washed in sterile phosphate buffer saline solution (PBS) at pH -7.4 by
centrifugation at 10000 rpm for 3 min at room temperature (21 6 2 °C). Then the bacteria were resuspended in PBS at
a concentration of 1·109 bacteria/ml. Bacteria concentration was calculated according to the turbidity measure at 660
nm (A660nm=1 correspond to bacterial suspension at ∼ 5·108 bacteria/ ml).
[0091] Dead bacterial suspensions at 1·109 bacteria/ml (negative controls) of these five species of bacteria were
prepared individually by addition of 20 ml of bleach containing 2.6 % active chlorine. Bacteria were treated with bleach
solution for 15 min. Dead bacteria were washed twice in sterile PBS by centrifugation at 10000 rpm for 3 min at room
temperature. The culturability of the negative controls was assessed by plating 100 ml of bacterial suspension onto LB
agar or Caso agar and incubating the plates at 37 °C for 72 h. None of the negative controls displayed any growth activity.
[0092] Bacteria (100 ml suspension at 1·109 bacteria/ml) were stained with 10 mM or 15 mM of pro-fluorophore (5-
CFDA, 5-PFDAE, 5-PFDAT, 5-PFDA, 5-COGDA, 5-POGDA or 5-POGAM) in 200 ml of PBS solution containing 0.6 %
of glutaraldehyde. Bacteria were incubated at 37 °C for 10 - 60 min with pro-fluorophore in darkness. After bacterial
staining, they were washed and resuspended in 100 ml of PBS as described above.
[0093] Staining of the bacterial suspension was observed under a fluorescent microscope. These bacteria were imaged
with a Leica DM5500 microscope equipped with FITC filter. Brightfield images indicated that bacteria appeared to have
normal physiology. Images were collected with a 100x objective. Fluorescence intensity of stained bacterial suspension
was also measured with FluoroLog®-3 (Horiba Jobin Yvon) spectrofluorometer equipped with sample stirring. Samples
were placed in fluorescence grade quartz cuvette having a volume of 1 ml. The excitation wavelength used was 488 nm
and emission wavelength used was 517 nm. The same experiment was repeated three times (n = 3).
[0094] As shown in Figure 3, treatment of bacterial suspensions with 5-POGDA and 5-POGAM stained only viable E.
cloacae (Fig. 3a), C. indologenes (Fig. 3b), and P. aeruginosa (Fig. 3c), which are all gram-negative bacteria, and also
viable (gram-positive) B. subtilis (Fig. 3d). No fluorescence signal was detected by microscopy analysis with the dead
bacteria. The same results were obtained with other species such as the coliform bacteria Citobacter freudii, Klebsiella
oxytoca and the non-coliform bacteria Chryseobacterium indologenes and Comamonas testosteroni/alcaligenes (data
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not shown).
[0095] Moreover, viable gram-negative bacteria like E. Cloacae, C. indologenes, P. aeruginosa incubated with 5-
POGDA or 5-POGAM have brighter fluorescence than 5-CFDA stained bacteria. As shown in Figure 3d, the fluorescence
intensity of the stained B. subtilis with 5-CFDA is higher than the staining with 5-POGDA and 5-POGAM. These results
suggest that the pro-fluorophores 5-POGDA and 5-POGAM are specifically useful for detecting viable gram-negative
bacteria.
Labeling of viable E. coli
[0096] The pro-fluorophores according to the present invention are preferably used to label E. coli cells. Viable or
dead E. coli (ATCC 8739) are incubated with these fluorophores and commercial 5-CFDA as described above. Fluo-
rescent microscopy analysis is used to show that 5-PFDAE, 5-PFDAT, 5-PFDA, 5-COGDA, 5-POGDA and 5-POGAM
can be unblocked by the bacterial endogenous esterase activity. Glutaraldehyde is added to the incubation solutions to
improve the retention of the fluorophores in bacteria.
[0097] Figure 4 shows microphotographs of viable or dead E. coli (ATCC 8739) incubated with different pro-fluorophores
(15 mM) for 30 min at 37 °C, overlaid with brightfield images. Bacteria were washed before being imaged with a Leica
DM5500 microscope, 100x objective. Scale bars indicate 10 mm.
[0098] As shown in Figure 4, viable E. coli can be specifically stained with high fluorescence intensity using the esterified
pro-fluorophores 5-PFDA, 5-COGDA, 5-POGDA and 5-POGAM.
[0099] Viable E. coli treated with 5-PFDAE showed a weaker green fluorescence, as compared to 5-CFDA staining.
No fluorescence signal of dead bacteria was detected. However, dead and viable E. coli treated with 5-PFDAT become
fluorescent. Thus, 5-PFDAT treatment is not adapted to distinguish between viable or dead E. coli. It is assumed that
the thiourea functional group of 5-PFDAT interacts with compounds of the E. coli membrane. Dead E. coli fluorescence
staining with 5-PFDAT was probably due to non-enzymatic hydrolysis.
[0100] Figure 5 shows the effect of the pro-fluorophore on the fluorescence intensity. Viable or dead E. coli (ATCC
8739) were incubated with different pro-fluorophores (10 - 15 mM) for 30 min at 37 °C. After washes, fluorescence of
the E. coli suspension was measured with a FluoroLog®-3 spectrofluorometer (excitation wavelength: 488 nm, emission
wavelength: 517 nm). Relative rates of viable E. coli fluorescence intensity were calculated by normalizing the difference
of viable E. coli fluorescence intensity and dead E. coli fluorescence intensity with 5-CFDA staining.
[0101] The Bacterial fluorescence intensity measured by spectrofluorometry shows that there is no fluorescence in-
tensity gain with 5-PFDAE containing an ester functional group, as compared to 5-CFDA which contains carboxylic acid
functional group.
[0102] However, as also observed in the microscopy analysis, viable E. coli cells incubated for 30 min at 37 °C with
5-POGDA exhibit a fluorescence intensity approximately 6 times higher than 5-CFDA treated viable E. coli.
[0103] Viable E. coli stained with 5-POGAM, 5-PFDAE or with 5-COGDA, have a fluorescence intensity between two
and three times higher than with 5-CFDA staining.
[0104] Further experiments show that an increase of viable E. coli fluorescence intensity is obtained up to about 15
mM for 5-POGDA and 5-POGAM. Using higher concentrations of mM of 5-POGDA or 5-POGAM in the range between
20 - 40 mM resulted in a saturation process. 40 mM of 5-POGDA or 5-POGAM still provide a stronger E. coli staining
than 5-CFDA or 5-PFDA (data not shown).
[0105] Figure 6 shows the effect of the incubation time on viable E. coli fluorescence intensity. Viable E. coli (ATCC
8739) were incubated with different pro-fluorophores (15 mM) at 37 °C for 10 - 60 min. After washes, E. coli fluorescence
suspension was measured with FluoroLog®-3 spectrofluorometer (excitation wavelength: 488 nm, emission wavelength:
517 nm).
[0106] As can be seen in Figure 5, longer pro-fluorophore incubation with E. coli results in an increase of fluorescence
intensity accumulated in the bacteria. The differences of the fluorescence signals between the respective pro-fluorophores
are conserved throughout 60 minutes. These results suggest that tested pro-fluorophores differ with respect to uptake
in the bacteria and hydrolysis speed of the blocking group. The addition of an amido propyl functional group (5-PFDA)
instead of a carboxylic functional group (5-CFDA) promotes the pro-fluorophore uptake into E. coli, since 5-PFDA
incubation for 10 to 60 min shows a higher fluorescence intensity than incubation with 5-CFDA.
[0107] Fluorine substitution of 5-PFDA gives 5-POGDA having a higher hydrolysis rate, as shown in Figure 1. Accord-
ingly, 5-POGAM offers a compromise between greater chemical stability and a slower but still efficient unblocking reaction
by esterase hydrolysis in E. coli as compared to 5-POGDA.
[0108] An incubation time of 30 min at 37 °C was found to be sufficient for generating a strong fluorescence signal in
order to easily distinguish viable from dead E. coli, and at the same time providing a low background due to spontaneous
hydrolysis of the pro-fluorophore. Thus, incubation with 5-POGAM (15 mM, 37 °C) has the advantage of producing a
three times brighter E. coli fluorescence than 5-CFDA and being much more stable in aqueous solution, as compared
to 5-PFDA and 5-COGDA.
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Immunofluorescence and viability staining of E. coli
[0109] One of the currently challenge in the water industry is to detect specific viable bacteria in drinking water. Actually,
the need for more rapid and sensitive tests is essential. The above tests show that viable laboratory strains of E. coli
are advantageously stained with pro-fluorophores of the present invention such as 5-POGAM and 5-POGDA.
[0110] In the following tests, different waterborne E. coli species are detected using an immunological approach.
[0111] Environmental E. Coli (EC18) were cultivated and re-suspended in PBS as described above. A dead bacterial
suspension was also prepared as previously described. Dead or viable E. coli (EC18) (100 ml of suspension at 1.109
bacteria/ml) were incubated with rabbit anti-EC18 polyclonal antibodies (anti-EC18 pAb) (dilution 1/20) for 1 h at room
temperature. This anti-EC 18 pAb was obtained from immunized rabbit with inactivated EC18 (Eurogentec). Bacteria
were washed in PBS by centrifugation at 10000 rpm for 3 min at room temperature. Then, they were resuspended in
200 ml of PBS solution containing 0.6 % of glutaraldehyde with 15 mM of 5-POGDA and incubated for 30 min at 37 °C
in the absence of light. Following several washes with PBS as described above, dead or viable E. coli (EC18) were re-
suspended in 200 ml of PBS and incubated for 1 h at room temperature in the absence of light with AlexaFluor 568
labeled anti-rabbit immunoglobulin (dilution 1/1000) (Molecularprobes, A11036). Bacteria were washed twice and re-
suspended in 100 ml of PBS. They were imaged with a Leica DM5500 microscope equipped with FITC and Cy3 filters.
Images were collected with a 100x objective. The same experiment was repeated three times (n = 3).
[0112] Dead and viable E. coli (EC18) were visualized as red cells after incubation with rabbit anti-EC18 polyclonal
antibodies (anti-EC18 pAb) and AlexaFluor 568 labeled anti-rabbit immunoglobulin. Staining of viable E. coli with 5-
POGDA resulted in a bright green fluorescence. Bacteria were washed before imaged with a Leica DM5500 microscope,
100x objective. Scale bars: 10 mm (data not shown).
[0113] The immunofluorescence assay indicated that the anti-EC18 pAb reacts equally with viable and dead cells.
When these treated cells coated with antibodies are incubated with 5-POGDA, viable cells have a green fluorescence
and dead cells have no green fluorescence.
[0114] In a further test, antibodies anti-EC18 pAB and pro-fluorophores (5-POGDA, 5-POGAM) were used to immobilize
E. coli (EC18) on beads and to reveal the immobilized bacteria respectively. Immunocapture of E. coli on beads was
done in order to concentrate the fluorescent signal in order to improve the detection of the viable cells. In these exper-
iments, Protein G Sepharose beads coated with goat-anti-rabbit immunoglobulins were used.
[0115] Environmental E. coli (E18) were cultivated and re-suspended in PBS as previously described. E. coli (EC18)
(100 ml of suspension at 1*109 bacteria/ml) were incubated with rabbit anti-EC18 polyclonal antibodies (anti-EC18 pAb)
or pre-immune control rabbit serum without anti-EC18 antibodies (PI-pAb) (dilution 1/20) for 1 h at room temperature.
This control rabbit serum (PI-pAb) was obtained from a non-immunized animal (Eurogentec). It was used as a negative
control. Bacteria were washed three times in PBS by centrifugation at 10000 rpm for 3 min at room temperature.
[0116] Proteine G Sepharose 4 Fast Flow beads were washed three times in Milli-Q water and three times in PBS by
centrifugation at 2000 rpm for 2 min at 4 °C. Then 10 ml of sedimented beads were incubated with 20 mg of secondary
antibody goat-anti-rabbit immunoglobulin (Thermo Scientific Pierce, 31210) in 500 ml of PBS with 0.001% of NP40 for
1h at room temperature with gentle mixing on a wheel. After two washes with PBS, these 10 ml of sedimented Protein
G Sepharose beads coated with goat-anti-rabbit immunoglobulins were incubated with E. coli (100 ml of suspension at
1.109 bacteria/ml) coated with rabbit anti-EC18 antibodies in 400 ml of PBS with 0.001% of NP40 for 2 h at room
temperature with gentle mixing on a wheel. After several washes, bacteria immobilized on sedimented beads were
stained with 10 mM 5-CFDA or 5-POGDA or 5-POGAM in 200 ml of PBS and 0.6 % glutaraldehyde for 30 min at 37 °C
in darkness. Beads were washed twice and 50 ml of Trypan Blue solution (0.4 %) was added as a contrast agent. Beads
were imaged with a Leica DM5500 microscope equipped with FITC filters. Images were collected with a 63x objective.
[0117] Observation by fluorescence microscopy showed a green fluorescent signal corresponding to viable E. coli
(EC18) captured on beads. However, no fluorescent signal was detected on the beads in absence of anti-EC18 antibodies
(PI-pAb), suggesting that E. coli (EC18) cells did not bind unspecifically to the beads. Moreover, fluorescence intensity
of viable E. coli stained with 5-POGDA or 5-POGAM was still higher than the fluorescence intensity of E. coli stained
with 5-CFDA.
[0118] These results suggest that uptake of 5-POGDA and 5-POGAM is not hindered by the presence of antibodies
at the bacterial surface. Moreover, 5-POGDA or 5-POGAM used to stain viable bacteria did not perturb the binding
between antibodies and bacteria. Therefore, 5-POGAM and 5-POGDA are useful for the detection of immobilized bacteria.
[0119] Other useful contrast agents are Commassie™ Brilliant Blue R and Bromophenol Blue. Briliant Blue R has
properties comparable to Trypan Blue but can be considered as a non CMR vital contrast agent. It is able to absorb the
fluorescence emitted from the fluorophores of the present invention, in particular 5-POG, but is exluded from vital cells.
Therefore, Brilliant Blue R is preferably used to eliminate all background due to non-enzymatic ester hydrolysis.
Bromophenol Blue will penetrate living cells and erase all fluorescence. Use of Bromophenol Blue therefore allows for
calibrating the fluorescence signal avoiding background after washes.
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Claims
1. A compound represented by the following formula (I)
wherein
each X is, independently from each other, one of H, F, Cl, Br, I, CN;
Z is one of O, Si, Ge or Sn;
R1 is hydrogen, -(C=O)-R4 or -CH2-O-(C=O)-R4, wherein R4 is substituted or unsubstituted alkyl having 1 to 18
carbon atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted
aralkyl having at least 7 carbon atoms, or wherein R1 is a residue derived from an amino acid, peptide, nucleotide
or oligonucleotide, monosaccaride or polysaccharide;
A is -NH2, -OR1 or -NR5(C=O)-R4 wherein R1 and R4 independently have the meaning as defined above and R5 is
H, substituted or unsubstituted alkyl having 1 to 18 carbon atoms, substituted or unsubstituted alkenyl having 2 to
18 carbon atoms, or substituted or unsubstituted aralkyl having at least 7 carbon atoms;
R2 and R3 are, independently from each other, H or -(C=O)-NR6R7, wherein at least one of R2 and R3 is not H, and
wherein R6 and R7 are selected from H, substituted or unsubstituted alkyl having 1 to 18 carbon atoms, substituted
or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having at least 7 carbon
atoms.
2. The compound of claim 1, represented by the following formula (II):
wherein X, R2 and R3 each have the meaning as defined above, each R1 are the same or different from each other
and are hydrogen, -(C=O)-R4 or -CH2-O-(C=O)-R4, wherein R4 independently is substituted or unsubstituted alkyl
having 1 to 18 carbon atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or
unsubstituted aralkyl having at least 7 carbon atoms.
3. The compound of claim 2, wherein X is H or F, and R4 independently is alkyl having 1 to 8 carbon atoms, more
preferably methyl or ethyl.
4. The compound of claim 2 or 3, wherein R2 or R3 is -(C=O)-NH-R7, wherein R7 is alkyl having 1 to 8 carbon atoms,
more preferably alkyl having 1 to 4 carbon atoms.
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5. The compound of any one of claims 2 to 4, wherein X is H, both R1 are either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4
is methyl, and one of R2 and R3 is -(C=O)-NH-R7, wherein R7 is selected from methyl, ethy, propyl, isopropy, butyl,
and isobutyl.
6. The compound of any one of claims 2 to 4, wherein X is F, both R1 are either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4
is methyl, and one of R2 and R3 is -(C=O)-NH-R7 wherein R7 is selected from methyl, ethy, propyl, isopropy, butyl
and isobutyl.
7. The compound of claim 1, represented by the following formula (III):
wherein X, R2 and R3 have the meaning as defined above, A is -NH2, or-NR5(C=O)-R4, R1 is hydrogen, -(C=O)-R4
or -CH2-O-(C=O)-R4, wherein each R4 independently is substituted or unsubstituted alkyl having 1 to 18 carbon
atoms, substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl
having at least 7 carbon atoms, and wherein R5 is H, substituted or unsubstituted alkyl having 1 to 18 carbon atoms,
substituted or unsubstituted alkenyl having 2 to 18 carbon atoms, or substituted or unsubstituted aralkyl having at
least 7 carbon atoms.
8. The compound of claim 7, wherein X is H or F, R4 independently is alkyl having 1 to 4 carbon atoms, more preferably
methyl or ethyl.
9. The compound of claim 8, wherein R5 is H or alkyl having 1 to 4 carbon atoms, more preferably H, methyl or ethyl.
10. The compound according to any one of claims 7 to 9, wherein R2 or R3 is -(C=O)-NH-R7, wherein R7 is alkyl having
1 to 8 carbon atoms, preferably alkyl having 1 to 4 carbon atoms.
11. The compound of claim 7, wherein X is H, A is -NR5(C=O)-R4, R1 is either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4 is
methyl, R5 is H, and one of R2 and R3 is - (C=O)-NH-R8 wherein R8 is selected from methyl, ethy, propyl, isopropy,
butyl, isobutyl.
12. The compound of claim 7, wherein X is F, A is -NR5(C=O)-R4, R1 is either -(C=O)-R4 or -CH2-O-(C=O)-R4, R4 is
methyl, R5 is H, and one of R2 and R3 is - (C=O)-NH-R8 wherein R8 is selected from methyl, ethy, propyl, isopropy,
butyl, isobutyl.
13. Use of a compound according to any one of claims 1 to 12 for staining a biological sample.
14. Use of claim 13 wherein the biological sample comprises a living cell.
15. Use of claim 14 wherein the sample cell is incubated with the compound of any one of claims 1 to 12 for a time
sufficient for the compound to yield a detectable fluorescence emission.
16. Use of claim 14 wherein the fluorescence emission is evaluated to discriminate living from non-living cells.
17. Use of any one of claims 14 to 16 wherein the living cell is a unicellular and multicellular organism.
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18. Use of any one of claims 12 to 17 wherein the biological sample is subjected to a cytometric assay.
19. Use of any one of claims 13 to 18 wherein the biological sample is treated with a contrast agent.
20. Use of claim 19 wherein the contrast agent is selected from the group consisting of Brilliant Blue R, Trypan Blue
and Bromophenol Blue.
21. Culture medium for microorganisms, comprising a nutrient medium and a compound according to any one of claims
1 to 12 dissolved in the nutrient medium.
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